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Objectives: To investigate the prevalence of dyslipidemia in Chinese lupus
nephropathy (LN) patients and examine differences in clinical characteris-
tics and outcomes between LN patients with and without dyslipidemia.
Methods: We included 1,150 LN patients registered from January 1, 2006 to
December 31, 2011 in our databank. Patients were divided into baseline dys-
lipidemia and non-dyslipidemia groups according to NCEP ATPIII criterion.
Logistic and Cox regression analyses modelswere used to explorerelated
risk factors (clinical, laboratory and treatment factors) for dyslipidemia
and their effects on all-cause mortality, CVD mortality, doubling creatinine
and end-stage renal disease (ESRD), respectively.
Results: The prevalence rate of dyslipidemia in LN patients was 91.4% in our
center. Patients with dyslipidemia showed severe proteinuria, higher SLE-
DAI, higher rate of hypertension, AKI, hyperuricemia, hypoalbuminemia,
crescents and interstitial inflammation than patients with normal lipids.
Multivariate logistic regression analysis indicated that high triglyceride and
low HDL-C were associated with SLEDAI (OR Z 1.05, 95% CI: 1.02e1.08,
P< 0.001 and OR Z 1.04, 95% CI: 1.01e1.07, P Z 0.001, respectively) and
eGFR (OR Z 0.97, 95% CI: 0.94e0.99, P Z 0.044 and OR Z 0.96, 95% CI:
0.93e0.99, P Z 0.003, respectively). 24-hour proteinuria was associated
with high total cholesterol (ORZ 1.24, 95% CI: 1.16e1.33), high triglyceride
(OR Z 1.14, 95% CI: 1.07e1.22) and high LDL-C (OR Z 1.15, 95% CI:
1.09e1.21) (all P values< 0.001). During a median follow-up of 56 months
(1e206months), 815 patients (71%) completed the follow-up, of which 100
patients (12%) experienced doubling creatinine, 76 (9%) had ESRD, and
102(13%) deaths occurred, 20(20%) of which were associated with CVD. In
Cox analysis, low HDL-C was associated with all-cause mortality (HR 2.47,
95% CI 1.05e5.79, P Z 0.038) after adjustment for age, gender, eGFR, hy-
pertension, hypoalbuminemia, SLEDAI, lipid-modifying and immunosuppres-
sive treatment.
Conclusion: Our results indicate that dyslipidemia was common in Chinese
LN patients. Low baseline HDL-C level increases risk of all-cause mortality,
which indicates that HDL-C might play an important role in prognosis of
LN.http://dx.doi.org/10.1016/j.hkjn.2015.08.1350135
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Objective: We aimed to assess the long-term prognosis in LN patients with
different proportions of crescents.
Methods: In this single-center, retrospective cohort study, 788 eligible LN
patients were enrolled from January, 1996 to December, 2011. Primary
endpoint was defined as a composite of doubling of baseline serum creati-
nine and ESRD, and the secondary endpoint was death.
Results:Among788 LNpatients, therewere406 patients presenting crescents at
biopsy. Comparisons between patients with and without crescent revealed that
crescent-featured individuals had worse baseline conditions in light of lower
eGFR (p< 0.001), higher blood pressure (p< 0.001), heavier proteinuria
(p< 0.001), severer microscope hematuria (p< 0.001), higher pathological
scores of activity index (AI) (p< 0.001) and chronicity index (CI) (p< 0.001).
Overamedian follow-up timeof56months (range:1e172months),nosignificant
differences were observed in both 10-year renal survival (86.2 vs. 89.7%,
p Z 0.637) and patient survival (84.3% vs. 89.2%, p Z 0.188). Crescent failed
to be the determinant of the composite endpoint comprising creatinine
doubling, ESRD and death (HRZ 0.82, 95% CI: 0.39e1.73, pZ 0.610). Besides,
weobserved that the increase in crescent proportion negatively related to base-
line eGFR (p-trend< 0.001), serum levels of hemoglobin (p-trend< 0.001), uric
acid(p-trendZ0.002), andpositivelyparalleledwithdegreesofpathologicalac-
tivity (AI:p-trend< 0.01) andchronicity (CI: p-trendZ0.003).CrescenticLNpa-
tientsexhibitedtheworst survivalwithanestimated5-year survival rateof78.9%
and 10-year of 52.6% (pZ 0.008). Higher proportion of crescents was demon-
strated to be an independent predictor of adverse outcomes (increase by every
10%: HR 1.17, 95% CI: 1.01e1.35, p Z 0.034) adjusting for age, sex, baseline
eGFR, proteinuria, AI and CI in multivariate Cox proportional hazard model.
Conclusion: The present cohort study showed that the overall long-term
renal survival of LN patients with and without crescents appeared compara-
ble, while increasing crescent proportion carried mounting risk of renal pro-
gression and death.Figure 1. Patient survival of LN with different proportions of crescents.http://dx.doi.org/10.1016/j.hkjn.2015.08.136
